These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 19685832)
1. [Antimicrobial peptide elicitors: a potential strategy against infections]. Prado-Montes de Oca E Gac Med Mex; 2009; 145(3):241-3. PubMed ID: 19685832 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptide elicitors: new hope for the post-antibiotic era. Prado Montes de Oca E Innate Immun; 2013 Jun; 19(3):227-41. PubMed ID: 23160387 [TBL] [Abstract][Full Text] [Related]
3. [Natural immunity--first line defense. New treatment against infections and autoimmune diseases in sight]. Bergman P; Gudmundsson GH; Agerberth B Lakartidningen; 2008 Aug 20-26; 105(34):2254-9. PubMed ID: 18785598 [No Abstract] [Full Text] [Related]
4. Role of antimicrobial peptides in host defense against mycobacterial infections. Méndez-Samperio P Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513 [TBL] [Abstract][Full Text] [Related]
6. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. Zaiou M J Mol Med (Berl); 2007 Apr; 85(4):317-29. PubMed ID: 17216206 [TBL] [Abstract][Full Text] [Related]
7. Host defense peptides for use as potential therapeutics. Zhang L; Falla TJ Curr Opin Investig Drugs; 2009 Feb; 10(2):164-71. PubMed ID: 19197794 [TBL] [Abstract][Full Text] [Related]
8. Host defense peptides and the new line of defence against multiresistant infections. Hirsch T; Jacobsen F; Steinau HU; Steinstraesser L Protein Pept Lett; 2008; 15(3):238-43. PubMed ID: 18336350 [TBL] [Abstract][Full Text] [Related]
9. [Biological alternatives to antibiotics]. Sliwa-Dominiak J; Witkowska M; Deptuła W Przegl Epidemiol; 2010; 64(3):399-403. PubMed ID: 20976953 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. Rivas-Santiago CE; Hernández-Pando R; Rivas-Santiago B Immunotherapy; 2013 Oct; 5(10):1117-26. PubMed ID: 24088080 [TBL] [Abstract][Full Text] [Related]
11. New approaches in peptide antibiotics. Vaara M Curr Opin Pharmacol; 2009 Oct; 9(5):571-6. PubMed ID: 19734091 [TBL] [Abstract][Full Text] [Related]
12. [Effector molecules of the innate immune system for treatment of wound infections]. Steinsträsser L; Langer S; Lehnhardt M; Steinau HU Chirurg; 2007 Apr; 78(4):343-8. PubMed ID: 17377758 [TBL] [Abstract][Full Text] [Related]
16. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents. Kruse T; Kristensen HH Expert Rev Anti Infect Ther; 2008 Dec; 6(6):887-95. PubMed ID: 19053901 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides. Sharma RK; Reddy RP; Tegge W; Jain R J Med Chem; 2009 Dec; 52(23):7421-31. PubMed ID: 19655779 [TBL] [Abstract][Full Text] [Related]
18. The defences of the ocular surface. Bron AJ; Seal DV Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 1)():18-25. PubMed ID: 3520980 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases. Camó C; Bonaterra A; Badosa E; Baró A; Montesinos L; Montesinos E; Planas M; Feliu L Peptides; 2019 Feb; 112():85-95. PubMed ID: 30508634 [TBL] [Abstract][Full Text] [Related]
20. The interplay of innate immunity, adaptive immunity, and autoimmunity. Heymann WR J Am Acad Dermatol; 2007 Oct; 57(4):700-1. PubMed ID: 17870434 [No Abstract] [Full Text] [Related] [Next] [New Search]